AGEN
Price
$3.08
Change
-$0.19 (-5.81%)
Updated
Dec 12, 04:59 PM (EDT)
ORMP
Price
$2.49
Change
+$0.03 (+1.22%)
Updated
Dec 12, 04:59 PM (EDT)
76 days until earnings call
Ad is loading...

AGEN vs ORMP

Header iconAGEN vs ORMP Comparison
Open Charts AGEN vs ORMPBanner chart's image
Agenus
Price$3.08
Change-$0.19 (-5.81%)
Volume$4.11K
CapitalizationN/A
Oramed Pharmaceuticals
Price$2.49
Change+$0.03 (+1.22%)
Volume$5.82K
CapitalizationN/A
AGEN vs ORMP Comparison Chart
Loading...
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGEN vs. ORMP commentary
Dec 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGEN is a Hold and ORMP is a Hold.

COMPARISON
Comparison
Dec 13, 2024
Stock price -- (AGEN: $3.27 vs. ORMP: $2.46)
Brand notoriety: AGEN and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGEN: 55% vs. ORMP: 130%
Market capitalization -- AGEN: $74.14M vs. ORMP: $101.18M
AGEN [@Biotechnology] is valued at $74.14M. ORMP’s [@Biotechnology] market capitalization is $101.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $489.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.72B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGEN’s FA Score shows that 0 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • AGEN’s FA Score: 0 green, 5 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than AGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGEN’s TA Score shows that 5 TA indicator(s) are bullish while ORMP’s TA Score has 5 bullish TA indicator(s).

  • AGEN’s TA Score: 5 bullish, 3 bearish.
  • ORMP’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AGEN is a better buy in the short-term than ORMP.

Price Growth

AGEN (@Biotechnology) experienced а -4.66% price change this week, while ORMP (@Biotechnology) price change was -2.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.99%. For the same industry, the average monthly price growth was -6.13%, and the average quarterly price growth was +8.13%.

Reported Earning Dates

AGEN is expected to report earnings on Aug 08, 2024.

ORMP is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-0.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($101M) has a higher market cap than AGEN($74.1M). ORMP has higher P/E ratio than AGEN: ORMP (22.82) vs AGEN (0.46). ORMP YTD gains are higher at: 6.494 vs. AGEN (-80.251). ORMP has higher annual earnings (EBITDA): 9.44M vs. AGEN (-77.64M). ORMP has more cash in the bank: 142M vs. AGEN (44.8M). ORMP has less debt than AGEN: ORMP (429K) vs AGEN (78.4M). AGEN has higher revenues than ORMP: AGEN (160M) vs ORMP (0).
AGENORMPAGEN / ORMP
Capitalization74.1M101M73%
EBITDA-77.64M9.44M-823%
Gain YTD-80.2516.494-1,236%
P/E Ratio0.4622.822%
Revenue160M0-
Total Cash44.8M142M32%
Total Debt78.4M429K18,275%
FUNDAMENTALS RATINGS
AGEN vs ORMP: Fundamental Ratings
AGEN
ORMP
OUTLOOK RATING
1..100
5411
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10084
PRICE GROWTH RATING
1..100
9447
P/E GROWTH RATING
1..100
9649
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (67) in the Pharmaceuticals Other industry is in the same range as AGEN (97) in the Biotechnology industry. This means that ORMP’s stock grew similarly to AGEN’s over the last 12 months.

ORMP's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as AGEN (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to AGEN’s over the last 12 months.

ORMP's SMR Rating (84) in the Pharmaceuticals Other industry is in the same range as AGEN (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to AGEN’s over the last 12 months.

ORMP's Price Growth Rating (47) in the Pharmaceuticals Other industry is somewhat better than the same rating for AGEN (94) in the Biotechnology industry. This means that ORMP’s stock grew somewhat faster than AGEN’s over the last 12 months.

ORMP's P/E Growth Rating (49) in the Pharmaceuticals Other industry is somewhat better than the same rating for AGEN (96) in the Biotechnology industry. This means that ORMP’s stock grew somewhat faster than AGEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGENORMP
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 18 days ago
84%
Bullish Trend 17 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATLC61.981.73
+2.87%
Atlanticus Holdings Corp
PAYO10.360.23
+2.27%
Payoneer Global
NOW1147.1819.34
+1.71%
SERVICENOW
UNCY0.80N/A
+0.19%
Unicycive Therapeutics
ATKR88.69-0.33
-0.37%
Atkore

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with BPMC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then BPMC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
-1.99%
BPMC - ORMP
44%
Loosely correlated
-0.96%
BTAI - ORMP
44%
Loosely correlated
-1.91%
INO - ORMP
44%
Loosely correlated
N/A
MBIO - ORMP
44%
Loosely correlated
+6.99%
VERV - ORMP
44%
Loosely correlated
-6.25%
More